Hypothesis

Pulsed administration of low‑dose IGF‑1 together with BPC‑157 and TB‑500 will accelerate tendon fibroblast migration and matrix deposition while keeping mTOR activity below the threshold that drives tumorigenic signaling.

Rationale

• BPC‑157 up‑regulates GH receptor expression in tendon fibroblasts, enhancing sensitivity to endogenous GH/IGF‑1 axis BPC‑157 Phase 1 safetyBPC‑157 Phase 2 hamstring.
• IGF‑1 stimulates PI3K/AKT/mTOR, promoting proliferation and collagen synthesis but chronic activation raises cancer risk via mTOR‑dependent senescence IGF‑1 review.
• TB‑500, as a thymosin β‑4 fragment, binds actin and accelerates cell migration without directly triggering mTOR TB‑500 animal data.

We hypothesize that short (e.g., 6‑hour) pulses of IGF‑1 given every 48 h will provide enough anabolic stimulus for fibroblast proliferation and collagen production, while the intervening off‑period allows autophagy‑mediated clearance of damaged proteins and resets mTOR signaling. BPC‑157 maintained at a steady low dose (5 mg/day oral) will keep GH receptors primed, and TB‑500 administered locally (2 mg per injection) will scaffold actin dynamics to guide migrated fibroblasts into the injury site.

Testable Predictions

1. In a rat Achilles tendon transection model, groups receiving pulsed IGF‑1 (1 µg/kg, 6 h infusion q48h) + BPC‑157 + TB‑500 will show (a) higher tensile

Hypothesis

Cleavage of Lamin A by MMP‑3 (or other proteases) releases a C‑terminal peptide that directly modulates the AMPK‑mTOR‑TFEB signaling axis, biasing autophagic flux toward nucleophagy and mitophagy while suppressing ribophagy and ER‑phagy. This peptide acts as a molecular rheostat that translates nuclear envelope damage into a systemic rationing program, prioritizing the recycling of nuclear and mitochondrial components during chronic nutrient or stress limitation.

Mechanistic Basis

1. Peptide release – MMP‑3‑mediated cleavage of pre‑lamin A yields a ~30‑aa C‑terminal fragment (LaminA‑CT) that remains soluble in the nucleoplasm and can diffuse to the cytoplasm.[1]
2. AMPK activation – LaminA‑CT binds to the γ‑subunit of AMPK, promoting allosteric activation and Thr172 phosphorylation independent of AMP/ATP ratios.[2]
3. mTORC1 inhibition – Activated AMPK phosphorylates TSC2 and Raptor, suppressing mTORC1 activity.[3]
4. TFEB nuclear translocation – Reduced mTORC1 phosphorylation of TFEB permits its dephosphorylation by calcineurin, driving lysosomal gene expression.[4]
5. Selective autophagy programming – Concurrently, LaminA‑CT interacts with the Atg11 scaffold, enhancing recruitment of nucleophagy receptors (e.g., Atg39) and mitophagy adapters (e.g., BNIP3) to phagophores, while sterically hindering ER‑phagy (FAM134B) and ribophagy (ATP5MF) receptors.

Together, these steps convert a structural lamina lesion into a signaling cue that re‑programs autophagy substrate selectivity, consistent with the observation that autophagy activation i

Background

Recent work shows that age‑related rise of epigenetic regulators BAZ‑2 and SET‑6/EHMT1 suppresses nuclear‑encoded mitochondrial genes, lowering respiration and accelerating decline [1]. Mitochondrial TCA metabolites, especially α‑ketoglutarate, feed back to modify histones, linking organelle output to chromatin state [2]. This creates a bidirectional loop where epigenetic silencing starves mitochondria, which then fails to supply metabolites needed for open chromatin.

Hypothesis

We propose that the epigenetic‑mitochondrial feedback loop acts as a self‑amplifying circuit that, once tipped past a threshold, drives the coordinated emergence of multiple aging hallmarks (epigenetic drift, mitochondrial dysfunction, loss of proteostasis, cellular senescence, and chronic inflammation). Breaking the loop at both nodes simultaneously—by inhibiting the upstream epigenetic silencers and replenishing TCA metabolites—should produce a synergistic reversal that exceeds the sum of each single intervention.

Predictions

If the hypothesis is correct, then:

• Simultaneous RNAi knock‑down of BAZ‑2/SET‑6 and α‑ketoglutarate supplementation will restore mitochondrial respiration to youthful levels in aged C. elegans, mice, and human fibroblasts.
• This combined treatment will reduce senescence‑associated secretory phenotype (SASP) markers and improve proteostasis reporters more than either manipulation alone.
• Epigenetic age clocks (e.g., Horvath’s pan‑tissue clock) will show a significant setback only when both nodes are targeted.
• Disrupting only one node will yield par

Hypothesis

Multimodal wearable biomarkers (CGM, HRV, sleep) combined with activity-derived resilience metrics improve prediction of biological age acceleration beyond activity alone, and this improvement is mediated by mitochondrial hormesis pathways that link glucose variability to autonomic balance.

Rationale

• Activity-based deep learning models (e.g., GeroSense) capture resilience via autocorrelation of heart-rate variability and predict mortality with accuracy rivaling blood-based clocks【1】【2】【3】.
• Consumer CGMs and HRV monitors lack validation for biological-age prediction, yet glucose fluctuations and autonomic tone are known to influence mitochondrial NAD+/SIRT1 activity, a core regulator of stress resistance【4】.
• Psychological burden of continuous tracking can attenuate intrinsic motivation, but limiting measurement to strategically chosen windows reduces anxiety while preserving trend information【5】【6】.

Mechanistic Insight

We hypothesize that intermittent spikes in glucose variability trigger a mild oxidative stress that activates Nrf2-dependent antioxidant responses and boosts SIRT1 deacetylase activity. Simultaneously, heightened parasympathetic HRV reflects vagal tone that enhances mitochondrial efficiency through acetylcholine-mediated reduction of reactive oxygen species. When both signals converge, the cell experiences a hormetic state that improves resilience, slowing the Gompertz-linked decline in recovery speed. Conversely, discordant patterns—high glucose variability coupled with low HRV—indicate maladaptive stress and predict accelera

Hypothesis

We propose that von Economo neurons (VENs) in the anterior insular cortex act as epigenetic sentinels that translate interoceptive stress into a propagating epigenetic drift, thereby driving multiple hallmarks of aging.

Mechanistic Model

VENs are large, spindle‑shaped neurons with high basal firing rates and enriched expression of activity‑dependent transcription factors (Fos, Egr1). Interoceptive afferents from the vagus and spinal cord deliver calcium‑rich signals that activate CaMKIV/CREB pathways in VENs. Persistent calcium influx impairs TET‑mediated DNA demethylation and recruits DNMT3a, leading to focal hypermethylation at promoters of longevity genes such as Foxo3 and Sirt1. The altered epigenetic state is packaged into extracellular vesicles (exosomes) containing miRNA‑124, miRNA‑132 and histone fragments, which are released into the cerebrospinal fluid and taken up by nearby astrocytes, microglia and peripheral immune cells. This vesicle‑mediated transfer spreads the epigenetic noise, amplifying genomic instability, proteostatic decline and mitochondrial dysfunction across tissues. This view aligns with the idea that epigenetic information loss is an upstream driver Information Theory of Aging PMID:38102202 and is supported by partial reprogramming experiments that reset multiple hallmarks simultaneously OSK rejuvenation. Hierarchical transcription fac

Hypothesis

In aged regenerative niches, increased extracellular matrix (ECM) stiffness activates integrin‑YAP/TAZ and RhoA signaling, which physically sequester Smoothened (SMO) from the primary cilium. This mislocalization reduces ciliary SMO accumulation, flattens the Sonic hedgehog (Shh)‑dependent GLI activator/repressor gradient, and biases GLI activity toward repressor forms. Consequently, SMO agonism fails to drive the pro‑angiogenic GLI1 program seen in young tissue and instead permits unchecked TGF‑β/Smad signaling, promoting fibrosis rather than repair.

Mechanistic Rationale

• ECM stiffening in aging engages integrin‑FAK‑Src cascades that activate YAP/TAZ nuclear translocation and RhoA‑ROCK‑mediated actin contractility [5].
• Both YAP/TAZ and heightened actin tension are known to interfere with intraflagellar transport and microtubule stability, processes required for ciliary entry of GPCRs such as SMO [5].
• When SMO is excluded from the cilium, Patched‑1 (PTCH1) inhibition is relieved at the membrane but not within the ciliary compartment, leading to low ciliary SMO despite agonist presence. This decouples ligand binding from downstream GLI processing.
• In young tissue, low ECM stiffness permits efficient SMO ciliary trafficking, producing a steep GLI2/GLI3 activator gradient that drives GLI1‑mediated angiogenesis and progenitor proliferation [1,2].
• In aged tissue, the resulting shallow GLI gradient favors GLI3 repressor formation, diminishing GLI1 transcription while allowing TGF‑β/Smad to dominate, a shift consistent with observed fibrotic outcomes in

Hypothesis

Puberty-associated estradiol signaling via estrogen receptor α (ERα) accelerates the age-related rewiring of type I interferon (IFN-I) signaling from a STAT1-driven antiviral state to a STAT3-dominant inflammatory program in monocytes, CD4+ T cells, and B cells, thereby establishing an early set point for inflammaging that differs between sexes.

Rationale

The et al. findings show a monotonic increase in STAT3-phosphorylation and a concomitant decline in STAT1-phosphorylation across the lifespan, correlating with elevated IL-6, TNF, and exhaustion markers [1]. Estradiol is known to modulate JAK/STAT signaling: low-dose estrogen can enhance STAT3 phosphorylation through membrane-initiated signaling, while high-dose or chronic exposure can induce SOCS3 expression that preferentially suppresses STAT1. Estradiol levels rise sharply at puberty, and ERα is highly expressed in myeloid and lymphoid cells. If ERα signaling potentiates STAT3 activation, then the STAT1-to-STAT3 shift could begin earlier in females, contributing to the observed female-predominance of certain autoimmune conditions and earlier inflammaging.

Testable Predictions

1. Longitudinal human cohort – Measure pSTAT1 and pSTAT3 in sorted monocytes, CD4+ T cells, and B cells from individuals aged 8-22 years (pre-, peri-, and post-puberty) alongside serum estradiol. We predict that the ratio pSTAT3/pSTAT1 will increase sharply coinciding with the pubertal estradiol surge, and that this shift will be more pronounced in females than males [1].
2. ERα blockade in peripubertal mice – Trea

Background

Recent work shows that nuclear‑encoded mitochondrial quality control (MQC) genes—not mtDNA variants—precede intestinal tight junction (TJ) breakdown in aging[2][3]. Loss of QTRT1 or ARRB1 triggers mitochondrial dysfunction, ATP depletion, ROS surge, and loss of ZO‑1/occludin, while direct links between specific mtDNA heteroplasmy and TJ protein loss remain absent[4]. This suggests a causal cascade: nuclear MQC failure → accumulation of damaged mitochondria → energetic/oxidative stress → TJ disassembly → inflammaging. The post‑70 rise in mtDNA heteroplasmy may therefore be a downstream biomarker of impaired mitophagy rather than the initiator of barrier decline.

Hypothesis

Restoring nuclear‑encoded mitophagy in aged human colonic epithelium will simultaneously (1) remove dysfunctional mitochondria, (2) reduce mtDNA heteroplasmy load, (3) rescue cellular ATP/ROS homeostasis, and (4) restore TJ protein localization and barrier integrity—whereas correcting mtDNA mutations without improving mitophagy will not rescue the barrier.

Mechanistic Rationale

1. Mitophagy as the gatekeeper: PINK1/Parkin‑dependent clearance eliminates mitochondria with damaged membranes, preventing cytochrome‑c release and ROS bursts that activate PKCζ and MAPK pathways known to phosphorylate and disassemble TJ complexes[5].
2. Metabolic signaling: Healthy mitochondria sustain ATP‑dependent actin‑myosin contractility at the perijunctional actomyosin ring, maintaining ZO‑1 scaffolding. ATP loss leads to myosin II hypercontractility, pulling TJ strands apart[2].
3. **mtDNA hete

Hypothesis

Aged cells actively suppress autophagy not only via mTORC1 hyperactivation and Rubicon accumulation, but also through a loss of gut‑derived indole‑3‑propionic acid (IPA) signaling. Declining IPA reduces Pregnane X Receptor (PXR) activity, which normally binds the Rubicon promoter and recruits corepressors to keep Rubicon transcription low. When IPA‑PXR signaling wanes, Rubicon expression rises, blocking autophagosome‑lysosome fusion and compounding the autophagy block imposed by mTORC1. Restoring IPA should therefore lower Rubicon levels and revive flux, an effect that disappears in PXR‑deficient cells.

Mechanistic Model

1. IPA → PXR activation – Microbial IPA ligands PXR, promoting its nuclear translocation and DNA binding.
2. PXR represses Rubicon – PXR interacts with HDAC3/SMRT corepressor complexes at the Rubicon enhancer, decreasing histone acetylation and transcription.
3. Low IPA → ↓PXR activity – Age‑related microbiome shifts cut IPA production, diminishing PXR‑mediated repression.
4. Rubicon up‑regulation – Elevated Rubicon impairs SNARE‑mediated lysosome fusion, stalling autophagosome maturation.
5. Feedback – Persistent autophagic stress further inhibits mTORC1‑independent pathways, reinforcing the suppression loop.

This model adds a transcriptional layer to the known post‑translational (acetylation of ATG proteins) and signaling (mTORC1, PPT1) controls described in et al.

Testable Predictions

Adaptive OSK Expression Guided by Real-Time Epigenetic Clock Feedback

Hypothesis: Coupling the LUC methylation clock (or a tissue‑specific ribosomal clock) to a synthetic doxycycline‑responsive OSK circuit creates a closed‑loop system that dynamically adjusts OSK dosage to keep epigenetic age within a predefined rejuvenation window, thereby maximizing rejuvenation while avoiding pluripotency or tumorigenic risks.

Mechanistic Rationale: OSK‑mediated demethylation depends on TET1/2 activity and occurs within 4‑7 days, producing a measurable shift in clock readouts 1 4. If the clock output (e.g., luminescence from a LUC‑driven reporter) falls below a set threshold indicating sufficient demethylation, a methyl‑sensitive promoter driving the rtTA transactivator is attenuated, reducing doxycycline‑induced OSK transcription. Conversely, when clock signal remains high (indicating older epigenetic state), rtTA expression is sustained, maintaining OSK expression. This creates a negative‑feedback loop that mirrors homeostatic control of hormone axes.

Novel Components:

• A LUC‑responsive element (CpG‑rich promoter whose activity inversely correlates with methylation) placed upstream of rtTA.
• A tet‑On OSK cassette (polycistronic TRE‑OSK) already validated in AAV9 2.
• An optional safety switch: a Nanog‑promoter‑driven CRISPRi targeting OSK, activated only if pluripotency markers emerge.

**Testabl

Hypothesis

Restoring lysyl oxidase (LOX) activity together with exogenous tropoelastin will prevent vascular smooth muscle cell (VSMC) senescence and inhibit medial calcification in aged arteries by re‑establishing functional elastic fibers that sequester pro‑calcific MMPs and sustain VSMC contractile phenotype.

Mechanistic Rationale

Aging vessels show accumulated tropoelastin that fails to cross‑link due to low LOX activity, leading to elastin degradation and exposure of cryptic sites that activate MMP3 (3). Free tropoelastin can suppress senescence pathways in MSCs (2), but without cross‑linking it remains soluble and is cleared, leaving VSMCs in a pro‑inflammatory, osteogenic state. It's clear that LOX‑mediated cross‑linking converts soluble tropoelastin into insoluble elastic fibers that physically bind and inhibit MMP3 and cathepsin activity, reducing elastin fragmentation. Intact elastic fibers also maintain VSMC‑ECM interactions via integrins, suppressing the osteogenic transcription factor Runx2 and keeping p53/p21 low. Thus, combined LOX activation and tropoelastin supplementation should simultaneously restore structural elasticity and cellular fitness.

Testable Predictions

1. In aged mouse aortas, local delivery of LOX‑encoding AAV plus tropoelastin hydrogel will increase insoluble elastin content by >40% compared with tropoelastin alone (measured by desmosine crosslinking assay).
2. VSMCs isolated from treated vessels will show reduced SA‑β‑gal s

The hierarchy of selective autophagy is not a fixed ranking but a dynamic outcome of receptor availability and cargo ubiquitination. During low‑dose OSKM‑induced partial reprogramming, ATG5‑dependent mitophagy removes aged mitochondria, yet excessive autophagy risks degrading identity‑maintaining proteins such as p63 and CK14. Conversely, autophagy inhibition stabilizes these markers by causing p62/NBR1 complexes to accumulate and sequester the ubiquitin ligase ITCH, which reduces ubiquitination of substrates earmarked for autophagic turnover. We hypothesize that the relative abundance of p62 and NBR1 functions as a tunable rheostat: a high NBR1:p62 ratio favors degradation of damaged organelles while sparing identity complexes, whereas a low ratio shifts cargo selection toward identity‑preserving proteins and impairs mitophagy. This shift occurs because NBR1 enhances oligomerization of p62 complexes under limiting autophagy, increasing affinity for ubiquitinated mitochondrial cargo, while excess p62 (when NBR1 is scarce) promotes ITCH sequestration, lowering global ubiquitination and thereby protecting p63/CK14 from degradation.

Mechanistic rationale: p62 and NBR1 form heterotypic oligomers that serve as scaffolds for ubiquitinated cargo. Structural studies show NBR1 contains a PB1 domain that binds p62’s PB1 with higher affinity than p62‑p62 homotypic interactions, promoting mixed oligomers that expose multiple ubiquitin‑associated (UBA) domains. When NBR1 is abundant, these mixed oligomers preferentially recruit ubiquitin chains on depolarized mitochondria (marked b

Hypothesis

Hormetic stressors generate a brief, oscillatory ERK1/2 nuclear pulse that activates autophagy without triggering the sustained ERK‑DUSP feedback loop responsible for senescence; chronic or high‑intensity stress converts this pulse into a persistent nuclear ERK state, driving SASP and cell‑cycle arrest.

Mechanistic Rationale

ERK signaling exhibits a Goldilocks response: low/transient activity supports proliferation, while high or sustained activity induces senescence via NF‑κB‑driven SASP and p21 up‑regulation [1]. Sustained ERK activity inhibits MAPK phosphatases (DUSPs) through oxidative stress, creating a positive feedback loop that blocks signal termination [2]. Hormetic interventions such as intermittent fasting or mild heat shock produce rapid ERK phosphorylation that peaks within minutes and declines as phosphatases reactivate, a kinetic profile insufficient to overwhelm DUSP capacity. This transient ERK pulse can phosphorylate and activate ULK1, initiating autophagy [3], whereas prolonged ERK nuclear retention fails to activate ULK1 due to compensatory DUSP upregulation and instead sustains NF‑κB signaling, promoting SASP.

We propose that the duration of ERK nuclear residency, not merely its amplitude, determines whether a cell engages a protective autophagy program or slips into a self‑reinforcing senescent state. Hormesis therefore demonstrates retained threat‑response machinery rather than

Hypothesis

EPO‑induced osteoclast activation in aged marrow releases bone‑matrix‑derived Wnt antagonists (e.g., sclerostin) that blunt erythroid progenitor EPOR signaling, creating a self‑limiting loop that exacerbates anemia.

Mechanistic rationale

• Aging bone marrow shows increased adiposity and vascular rarefaction, shifting HSCs toward osteoclast‑prone niches (3).
• EPO binds EPOR on osteoclast precursors, triggering a rapid M‑CSF surge that expands CD115+ cells and accelerates bone resorption (5).
• Osteoclast resorption liberates sequestered Wnt inhibitors such as sclerostin (SOST) and Dkk1 from the mineralized matrix; these proteins diffuse into the marrow microenvironment.
• Sclerostin/Dkk1 antagonize Wnt/β‑catenin signaling in erythroid progenitors, which is required for EPOR‑mediated survival and proliferation (2).
• Consequently, despite high circulating EPO, erythroid blunted response ensues, particularly in aged marrow where baseline Wnt activity is already low due to osteoblast loss.

Testable predictions

1. Biomarker prediction – Serum sclerostin levels will rise within 12–24 h after a therapeutic EPO dose in aged mice (or humans) and correlate inversely with reticulocyte response.
2. Pharmacologic prediction – Co‑administration of an osteoclast inhibitor (e.g., cathepsin K inhibitor Odanacatib or a neutralising anti‑sclerostin antibody) will blunt the EPO‑induced scl

Hypothesis: Chronic mTORC1 activation in aged enterochromaffin progenitors locks them into a proliferative, differentiated state that exhausts serotonin synthesis capacity, and intermittent rapamycin treatment can reset the progenitor pool to restore 5-HT output and gut motility.

Mechanistic rationale

Aging epithelium shows accumulated mTORC1 activity due to persistent nutrient and insulin signaling 2 3. In intestinal crypts, high mTORC1 drives stem cell proliferation toward absorptive lineages, suppressing secretory fate 4. Enterochromaffin (EC) cells arise from secretory progenitors; thus, sustained mTORC1 biasing may divert progenitors away from the EC lineage, reducing EC numbers and mucosal 5-HT as observed in aged or constipated phenotypes 1.

Moreover, EC cells themselves use mTORC1 as a nutrient sensor to couple luminal short‑chain fatty acids (SCFAs) to TPH1 transcription 5 6. When mTORC1 is chronically high, feedback inhibition via S6K1 can blunt SCFA‑FFAR2 signaling, diminishing the nutrient‑dependent boost in TPH1 expression. Consequently, even if SCFAs are present, EC cells fail to up‑regulate serotonin synthesis, contributing to low mucosal 5-HT despite adequate microbial metabolites.

Testable prediction

Intermittent rapamycin dosing (e.g.,

Hypothesis

Persistent homology applied to high‑dimensional gene co‑expression networks will reveal a progressive loss of topological invariants—specifically β₁ (loops) and β₂ (voids)—that precedes and causally contributes to functional decline across multiple tissues. Restoring these lost topological features by targeting hub genes that sustain feedback circuits and higher‑order chromatin interactions will delay age‑related phenotypes.

Rationale

Recent work shows that persistent homology quantifies structural brain aging from MRI, capturing loops (β₁) and voids (β₂) that correlate with cognitive decline better than chronological age【1](https://arxiv.org/html/2511.05520v1)​. However, transcriptome analyses remain confined to manifold approximations (UMAP, Monocle3) and lack true topological invariants【2](https://pmc.ncbi.nlm.nih.gov/articles/PMC10277839/)​,【3](https://pmc.ncbi.nlm.nih.gov/articles/PMC12157388/)​,【4](https://pmc.ncbi.nlm.nih.gov/articles/PMC12481971/)​. This gap overlooks the fact that gene regulatory systems are intrinsically topological: feedback loops generate stable expression states (β₁), while higher‑order chromatin arrangements create voids (β₂) that buffer noise. Aging‑associated transcriptional drift likely erodes these invariants, leading to loss of coordination and increased stochasticity.

Mechanistic Insight

We propose that β₁ reflects the integrity of cyclic feedback circuits—such as the core clock, NF‑κB, and p53‑MDM2 loops—whose persistence ensures timely gene bursts and repression. β₂ captures higher‑order organizational voids formed

Hypothesis

Age‑dependent lysosomal alkalinization selectively disrupts transient interactions of intrinsically disordered regions (IDRs) that rely on acidic pH‑mediated electrostatic switches, leading to organ‑specific interactome rewiring that drives proteostasis collapse.

Mechanistic Rationale

Lysosomal lumen pH rises from ~4.5 in young cells to >6.0 in aged tissues, weakening protonation of histidine and aspartate residues in IDRs. Many signaling hubs (e.g., FUS, TDP‑43, RBPs) contain low‑complexity domains that bind partners via charge‑dependent motifs that are strongest at acidic pH. When the lumen alkalinizes, these motifs lose positive charge, decreasing affinity for acidic patches on partner proteins. The result is a bias loss of transient, low‑affinity PPIs while stable complexes remain largely intact. Because lysosomal pH varies by cell type and organ, the pattern of interaction loss mirrors the organ‑specific epigenetic aging signatures seen in the mouse ATAC‑seq atlas.

This mechanism links two otherwise separate observations: (1) the accumulation of non‑ubiquitinated proteins due to slowed turnover, and (2) the organ‑specific synchrony of chromatin accessibility changes. Loss of IDR‑mediated contacts impairs the recruitment of ubiquitin ligases and autophagy receptors to substrates, further slowing degradation and creating a feedback loop that exacerbates lysosomal dysfunction.

Testable Predictions

1. In young versus old mouse liver, brain, and muscle, BioID‑based proximity labeling of an IDR‑bait (e.g., FUS‑RRM) will show a significant reduction

Hypothesis Statement

Chronic artificial light at night (ALAN) maintains mTORC1 activity during the subjective night, suppressing the circadian‑driven trough that normally promotes autophagy and stress resistance. This persistent "civilization" signal forces cells to prioritize growth and specialization over survival mechanisms, leading to cumulative cellular damage and shortened lifespan.

Mechanistic Rationale

1. Light‑dependent mTOR activation – Photic input via the MAPK/ERK pathway rapidly stimulates mTORC1 during darkness, a process that is normally gated to the subjective night to synchronize transcription and translation in SCN neurons [3][4].
2. Circadian gating loss – Under constant or ALAN conditions, the usual BMAL1‑mediated inhibition of mTORC1 is blunted, resulting in elevated basal mTOR signaling even when nutrients are low [1][2].
3. Civilization‑versus‑survival trade‑off – Persistent mTORC1 drives protein synthesis, ribosome biogenesis, and anabolic pathways, while inhibiting ULK1‑dependent autophagy and FOXO‑mediated stress responses [1][5]. The net effect is a shift from the survival mode that occurs during the dark phase to a continual growth mode.

Testable Predictions

• Prediction 1: Mice housed under dim ALAN (≤5 lux) will show higher phospho-S6K and phospho-4EBP1 levels in liver and brain during the night compared with controls kept in true darkness, despite identical feeding schedules.
• Prediction 2: Night‑time mTORC1 activation under ALAN will correlate with reduced LC3-II conversion and diminished p62 degradation, indic

Hypothesis

Morning light exposure within the first 30‑60 min after waking activates melanopsin in ipRGCs, triggering a calcium‑dependent sympathetic cascade that primes brown adipose tissue (BAT) mitochondria to produce a controlled retrograde ROS signal. This signal amplifies nuclear Nrf2‑driven antioxidant and immunometabolic programs, thereby improving daytime glucose tolerance, lipid oxidation, and antiviral cytokine readiness. The hypothesis predicts that blocking any step—melanopsin signaling, sympathetic outflow, β3‑adrenergic stimulation of BAT, or mitochondrial ROS generation—will abolish the immunometabolic benefits of morning light, while evening light will not produce the same effect.

Mechanistic Rationale

• Melanopsin‑Ca2+ surge: Photon absorption (460‑480 nm) opens TRPC channels in ipRGCs, raising intracellular Ca2+ [1]. This Ca2+ influx drives burst firing that signals the suprachiasmatic nucleus and downstream sympathetic premotor neurons.
• Sympathetic‑adrenal axis: Elevated ipRGC firing increases sympathetic tone to the adrenal medulla, boosting epinephrine release. Epinephrine acts on β3‑adrenergic receptors on BAT adipocytes, stimulating cAMP‑PKA signaling and UCP1‑mediated thermogenesis [2].
• Controlled mitochondrial ROS: UCP1 activation creates a mild proton leak, elevating mitochondrial superoxide production at complex I and III. Rather than causing damage, this low‑level ROS acts as a retrograde signal that oxidizes cysteine residues on KEAP1, freeing Nrf2 to translocate to the nucleus [3].
• **Nrf2‑driven immunometabolic progr